OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.verified

OKUR

Price:

$2.33

Market Cap:

$31.48M

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

Industry

Biotechnology

IPO Date

Stock Exchange

NASDAQ

Ticker

OKUR

The ROE as of July 2025 (TTM) for OnKure Therapeutics, Inc. (OKUR) is -190.32%

According to OnKure Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -190.32%. This represents a change of 1.59% compared to the average of -11.25% of the last 4 quarters.

OnKure Therapeutics, Inc. (OKUR) Historical ROE (quarterly & annually)

How has OKUR ROE performed in the past?

The mean historical ROE of OnKure Therapeutics, Inc. over the last ten years is 11.48%. The current -190.32% ROE has changed -1758.48% with respect to the historical average. Over the past ten years (40 quarters), OKUR's ROE was at its highest in in the June 2024 quarter at 11.44%. The ROE was at its lowest in in the December 2024 quarter at -33.90%.

Quarterly (TTM)
Annual

Average

11.48%

Median

34.67%

Minimum

-50.73%

Maximum

54.23%

OnKure Therapeutics, Inc. (OKUR) ROE by Quarter and Year

Discovering the peaks and valleys of OnKure Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 54.23%

Minimum Annual Increase = -300.74%

Minimum Annual ROE = -50.73%

Quarterly (TTM)
Annual
YearROEChange
2024-50.73%-246.32%
202334.67%-36.07%
202254.23%-300.74%
2021-27.02%-158.45%

OnKure Therapeutics, Inc. (OKUR) Average ROE

How has OKUR ROE performed in the past?

The current ROE of OnKure Therapeutics, Inc. (OKUR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.72%

5-year avg

11.48%

10-year avg

11.48%

OnKure Therapeutics, Inc. (OKUR) ROE vs. Peers

How is OKUR’s ROE compared to its peers?

OnKure Therapeutics, Inc.’s ROE is

CompanyROEMarket cap

Build a custom stock screener for OnKure Therapeutics, Inc. (OKUR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OnKure Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OnKure Therapeutics, Inc. (OKUR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OnKure Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is OnKure Therapeutics, Inc.'s ROE?

How is the ROE calculated for OnKure Therapeutics, Inc. (OKUR)?

What is the highest ROE for OnKure Therapeutics, Inc. (OKUR)?

What is the 3-year average ROE for OnKure Therapeutics, Inc. (OKUR)?

What is the 5-year average ROE for OnKure Therapeutics, Inc. (OKUR)?

How does the current ROE for OnKure Therapeutics, Inc. (OKUR) compare to its historical average?